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Abstract 
Several effects of the neuroleptic agent haloperidol on the sarcoplasmic reticulum (SR) Ca-dependent adenosine 
triphosphatase (Ca-ATPase) and Ca transport are described. Haloperidol inhibits the Ca-ATPase activity in the presence of 
calcimycin. The effect depends on the conditions of preexposure of the membranes tothe drug: the inhibition increases with 
the preincubation time; Ca and Mg protect he enzyme against he effect of the drug. The inhibitory effect of haloperidol 
decreases upon increasing [Ca 2÷ ], at constant [Mg], and disappears at 20 mM [Mg] for any [Ca 2÷ ], and at 0.5 mM [Ca 2÷ ]
for any [Mg 2÷ ]. Haloperidol also inhibits phosphorylation f the enzyme by Pi, and ATP-dependent Ca z+ uptake, in both 
cases with apparent K i = 13.10-0.15 mM, and increases the rate of Ca efflux from preloaded vesicles in this concentration 
range. The results suggest that haloperidol interacts with the catalytic site, interfering with the effect of the divalent catalytic 
cation, but not at other steps of the enzymatic ycle, where Mg 2÷ and Ca 2+ are also activators. They are consistent with a 
reaction model where haloperidol interacts with the E 2 conformers of the enzyme, with lower affinity for the phosphoen- 
zyme than for the dephospho species. The inhibition of Ca uptake by SR vesicles is ascribed to an increased Ca 2+ 
permeability rather than to the inhibition of the Ca-ATPase, which requires higher concentrations of the drug. 
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1. Introduction 
The sarcoplasmic reticulum (SR) is a network of 
intracellular membranes; urrounding a closed space. 
The Ca-ATPase, an intrinsic protein of these mem- 
branes, actively transports Ca 2÷ from the myoplasm 
Abbreviations: SR, sarcoplasmic reticulum; Ca-ATPase, Ca- 
dependent adenosinetriphosphatase; Mops, 3-[N-morpholino]pro- 
pane-sulfonic acid; Tris, Tris[hydroxymethyl]aminomethane; 
EGTA, ethyleneglycol-bis(13-aminoethyl ether) N,N'-tetraacetic 
acid 
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into the SR lumen, at the expense of free energy of 
ATP hydrolysis. This enzyme has one high affinity 
ATP binding site (catalytic site) in the cytoplasmic 
domain and two high affinity Ca 2+ binding sites 
(transport sites) in the transmembrane domain [1]. 
Scheme 1, reproduced from Lacapere and Guillain 
[2], summarizes the cycle of the Ca-ATPase. It sim- 
plifies previous proposals [3,4] including only those 
steps referenced below. 
Ca~+o is myoplasmic Ca 2 + and Ca~i +) is intraretic- 
2+ ular Ca . In the clockwise or forward direction of 
the reaction, the enzyme hydrolyzes 1 mol of ATP 
and transports 2 tool of Ca 2+ per mol of cycles. The 
raising of 2+ [Ca0n)] forces step 2 backward thus inhibit- 
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membranes. This butyrophenone is probably the neu- 
roleptic agent most widely used in clinical medicine. 
The study was motivated by the possibility of an 
eventual link between the SR function and the neu- 
roleptic malignant syndrome, an infrequent picture 
caused by neuroleptic agents in genetically predis- 
posed patients [17], where an increased myoplasmic 
[Ca 2+] has been reported [18]. We found that 
haloperidol, with similar pharmacological effects as 
phenotiazines on the central nervous system, also 
shares common effects on Ca transport hrough the 
SR membranes, thus providing a biochemical support 
for further research on these putative peripheral ef- 
fects of the neuroleptic agents. 
ing the ATPase activity. E~ and E 2 represent wo 
different conformations of the enzyme. E~ is phos- 
phorylated by ATP (step 1, forward) and E 2 is 
phosphorylated by orthophosphate (Pi) (step 3, back- 
ward), in the same site. Phosphorylation through step 
1 requires the binding of two calcium ions to the 
transport sites and at least one divalent cation as an 
ATP cosubstrate which is often referred to as the 
catalytic cation, to differentiate from the transported 
cations. Phosphorylation through step 3 (backward) 
also requires a divalent cation as cosubstrate in the 
catalytic site. The physiological cosubstrate is Mg 
[3,5-7], but it can be replaced by other ions [2,8,9]. 
When Ca replaces Mg as the catalytic ion in the 
forward reaction, the phosphoenzyme formed under- 
goes a very low turnover, thus decreasing the steady- 
state rate of ATP hydrolysis [2,8]. Mg also acceler- 
ates other steps of the cycle [10-12]. 
Several hydrophobic drugs, such as propranolol 
and some local anaesthetics, have a direct effect on 
the SR Ca-ATPase activity and on the Ca 2+ perme- 
ability of the SR membranes [13-15]. It has been 
suggested that these drugs interact with the catalytic 
site of the enzyme conformer E 2 (Scheme 1). More 
recently L. de Meis [16] showed that several phenoti- 
azines also increase the Ca 2+ permeability of these 
membranes and inhibit the phosphorylation of the 
ATPase by Pi; the author put forward that the ob- 
served increased Ca 2+ efflux from previously loaded 
SR vesicles occurs through the pump, whose hydro- 
lytic and transport activities would became uncoupled 
by effect of the drugs. Herein, we describe several 
effects of haloperidol on Ca transport hrough SR 
2. Materials and methods 
SR membrane fragments were obtained from rab- 
bit fast skeletal muscles, as described by Champeil et 
al. [19]. The procedure yields a light fraction of 
microsomes, derived from the longitudinal SR 
tubules, isolated as sealed vesicles with ATP-depen- 
dent Ca accumulating ability. The protein concentra- 
tion of the SR suspensions was determined by the 
method of Lowry et al. [20], using bovine serum 
albumin as standard. 
For ATPase activity determinations, the SR mem- 
branes were exposed to haloperidol, at 37°C, pH 7.0, 
in the presence of different reactants, and under the 
conditions pecified below, for each case. The term 
preincubation is used to indicate the period of expo- 
sure of the SR membranes to haloperidol in the 
absence of ATP. Incubations of the SR membranes in
the presence of ATP, calcimycin and other reactants 
were also made at 37°C and pH 7.0. The reactions 
were stopped with 5% trichloroacetic acid (final con- 
centration); inorganic phosphate (Pi) was determined 
after precipitation of the denatured protein by the 
method of Baginski et al. [21] and taken as an index 
of the ATPase activity. Blanks were run in parallel 
without added SR membranes, and subtracted to all 
the experimental values. The results shown are repre- 
sentative of at least three similar experiments, in all 
cases. 
Phosphorylations with inorganic phosphate (Pi) 
were made at 22°C, pH 6.0 or 7.0, in the presence of 
10 mM MgC12, 1 mM EGTA, SR membranes, 32p i 
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and haloperidol as indicated in Section 3. The reac- 
tions started by addition of the SR membranes and 
were stopped with 5% trichloroacetic acid plus 15 
mM nonradioactive NaH2PO 4 (final concentrations). 
The mixtures were filtered through A /E  Glass Fiber 
Filters (Gelman Sciences, Ann Arbor, MI, USA), and 
exhaustively washed with 5% trichloroacetic acid and 
15 mM NaH2PO 4 . The filters were poured into 
counting vials with water for the determination of the 
Cerenkov radiation in 2, liquid scintillation counter. 
Blanks prepared without SR membranes were sub- 
tracted to the experimental values. 
For ATP-dependent calcium uptake determina- 
tions, SR vesicles preexposed to haloperidol were 
incubated at 37°C, for 1 min, in the presence of ATP, 
45CAC12, other reactants as detailed in Section 3, and 
without added precipitating anions. The reactions 
were stopped by filtration through 0.45 i-~m Millipore 
filters; the filters were immediately washed with cold 
and freshly prepared 2 mM LaC13, and the retained 
radioactivity was measured in a liquid scintillation 
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Fig. 1. Inhibition of the Ca-ATPase by haloperidol. ((3) SR 
membranes (0.1 mg protein/ml) were incubated in 50 mM 
MOPS-Tris (pH 7.0), 3 mM ATP, 3 mM MgC12, 100 mM KC1, 
0.1 mM CaC12, 0.1 mM EGTA, 10 IxM calcimycin, and 
haloperidol as indicated in the absissa, during 1 min. The reac- 
tions started by addition of the SR membranes to a mixture of the 
other eactants. (zx) 0.1 mg of SR protein were preincubated in 
0.2 ml of 250 mM Mops-Tris, 0.5 mM EGTA, and 1 mM 
haloperidol, during 20 min. Incubations (1 min) started by dilu- 
tion (1/5) of the preincubated SRmembranes in media rendering 
the final concentrations of tile same reactants as above. Incuba- 
tions and preincubations were at 37°C. The ATPase activity was 
determined asdescribed in Section 2. 
Table 1 
Ca and Mg prevent the inhibitory effect of haloperidol n the SR 
Ca-ATPase 
Divalent cations during preincubation 
(1) (2) (3) (4) 
Ca + Mg Ca Mg None 
Ca-ATPase activity 100_+4 84+_9 87_+4 14+3 
(% of control) 
0.1 mg of SR protein were incubated in 1 ml of media finally 
containing 50 mM Mops-Tris, 100 mM KC1, 3 mM MgCI2, 0.1 
mM CaC12, 0.1 mM EGTA, 10 txM calcimycin, 1mM haloperi- 
dol and 3 mM ATP, under the conditions specified in Section 2. 
The reactions started by addition of 30 ~1 of either ATP alone 
(1), ATP+Mg (2), ATP+Ca (3), or ATP+Ca+Mg (4), to 970 
Ixl of SR membranes preincubated for 20 min with the other 
reactants. The results are expressed in % of the ATPase activity 
measured without preincubation, with indication of the S.E.M. of 
six independent experiments. 
counter. For determinations of the SR Ca permeabil- 
ity, the vesicles were passively loaded in 10 mM 
45CAC12 overnight; thereafter, the suspensions were 
diluted in 5 mM EGTA and other reactants as speci- 
fied in Section 3; aliquots were taken at different 
times, filtered, and the trapped radioactivity was mea- 
sured as described above. 
Due to the marked hydrophobicity of haloperidol, 
it was dissolved as a 20 mM stock solution in 
ethanol/0.1 M HC1 (9:1, v /v) .  Since ethanol slightly 
inhibits the Ca-ATPase activity and the ATP-depen- 
dent Ca 2+ uptake, care was taken to keep constant 
the amount of the solvent in the different experi- 
ments, at values never larger than 5%. In control 
experiments, we discarded an eventual effect of 
haloperidol or ethanol on the trapping capacity of the 
filters, measuring Ca uptake in the absence of 
haloperidol and ethanol after separation of the mem- 
branes with Millipore filters previously soaked (5 
min) in water or in 5% ethanol with 1 mM haloperi- 
dol; this treatment of the filters did not affect their 
trapping capacity (data not shown). Furthermore, we 
did not detect differences in the protein concentra- 
tions of filtrates from samples without or with 1 mM 
haloperidol (data not shown), as reported [22] for 
other lipophilic reagents. In other controls we dis- 
carded an eventual effect of haloperidol on free Ca 2+ 
concentrations. We measured the absorbance of Ca- 
Arsenazo III complex for various micromolar Ca 2+ 
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concentrations in samples with and without haloperi- 
dol. The absorbance of the media added with 30 txM 
arsenaze III was measured at 655 nm. No differences 
were observed between samples with and without 
haloperidol (data not shown). 
Free calcium and magnesium concentrations were 
calculated with a computer program, as described by 
Fabiato and Fabiato [23], using the dissociation con- 
stants given by the authors. 
Disodium ATP, bovine serum albumin, cal- 
cimycin, arsenazo III, MOPS and Tris were pur- 
chased from Sigma (St. Louis, MO, USA). 32p-labeled 
H3PO 4 was obtained from the Comision Nacional de 
Energia Atrmica de la Repfiblica Argentina. 45CaC12 
was obtained from New England Nuclear (E.I. Dupont 
de Nemours, Boston, MA, USA). Haloperidol was a 
kind gift from Janssen Farmaceutica (Buenos Aires, 
Argentina). All other reagents were analytical grade. 
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Fig. 2. Effect of the preincubation time of the Ca-ATPase in 
haloperidol. 0.1 mg of SR protein were preincubated in 970 Ixl, 
in the presence of 0.6 mM haloperidol and other eactants, except 
ATP (O), or except ATP, Ca and Mg (•) ,  during the indicated 
periods. Thereafter, 2-minute incubations started by addition of 
30 p,1 of ATP, or ATP plus Ca and Mg, respectively. The final 
concentrations of the reactants and other conditions for determi- 
nations of the ATPase activity were as in Fig. 1 and as described 
in Section 2, respectively. 
Fig. 3. Effect of [Ca 2+ ] on the inhibition of the Ca-ATPase by 
haloperidol. 0 1 mg of SR protein was preincubated in 0.2 ml of 
250 mM MOPS-Tris, 0.5 mM EGTA, without ([] ,O, A ) or with 
(11,O,•) 1 mM haloperidol, and different amounts of CaCI 2, 
during 20 minutes. Thereafter, the samples were diluted 1/5 in 
media containing (final concentrations) 3 mM ATP, 100 mM 
KC1, 10 IxM calcimycin, and 0.6 (•,m),  3 (O,O) or 20 (zx ,• )  
mM MgC12. The absissa indicates free Ca concentrations during 
the 2 min incubations, calculated as described in Section 2. Inset: 
Effect of [Mg 2÷ ] on the inhibition of the Ca-ATPase by 
haloperidol. 0.1 mg of the protein was preincubated in 0.2 ml of 
250 mM Mops-Tris 0.5 mM EGTA, without (O) or with (• )  1 
mM haloperidol, and different amounts of CaC12 to give 0.5 mM 
free Ca concentrations, during incubations, in all cases. After 20 
min the samples were diluted 1/5 in the media containing ATP, 
KC1 and calcimycin as in Fig. 1 and MgC12 to give the free Mg 
concentrations i dicated in the absissa, for incubations during 2 
min. Other conditions are given in Section 2. 
low basal, Ca 2+- or MgZ+-dependent, ATPase activ- 
ity. The basal ATPase activity, measured in the pres- 
ence of 1 mM EGTA and without added Ca, was 
lower than 3% of the total ATPase activity, under 
optimal conditions for activation of the Ca-ATPase; it 
presumably derives from small amounts of contami- 
nant T tubules [24]. The use of the calcium ionophore 
calcimycin in ATPase activity determinations pre- 
vents the inhibitory effect of Ca accumulation i side 
the vesicles. 
Fig. 1 shows the effect of different concentrations 
of haloperidol on the SR Ca-ATPase activity. Under 
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these conditions, the apparent K i is approx. 0.4 mM. 
The figure also shows the effect of the preexposure 
of the SR membranes to 1 mM haloperidol, during 20 
min. The results indicate that the concentrations of
the drug during preincubations and incubations dif- 
ferently affect the ATPase activity. 
The inhibitory effect of haloperidol depends on 
other preincubation conditions. Table 1 shows the 
effect of the presence of Ca and/or Mg during 
preincubations with 1 rtLM haloperidol. Fig. 2 shows 
the effect of the preincubation of SR membranes in
0.6 mM haloperidol for different periods. The in- 
hibitory effect of haloperidol increases with the 
preincubation time, in the absence of Ca and Mg in 
the media, and the presence of the cations impairs the 
development of the inhibitory effect of the drug 
(Table 1 and Fig. 2). 
The inhibition of the Ca-ATPase activity by 
haloperidol as a function of [Ca 2+ ] is shown in Fig. 
3, for three different Mg concentrations. It can be 
appreciated that for optimal [Mg] (3 raM), and in the 
absence of haloperidol, the enzymatic activity reaches 
maximal values at less than l0 ixM [Ca=+], and 
decreases upon increasing [Ca2+]. The inhibition of 
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Fig. 4. Phosphorylation f the Ca-ATPase by Pi. (A) SR membranes (1.3 mg/ml) were incubated at22°C and pH 7.0 in media containing 
50 mM MOPS-Tris, 10 mM MgC12, 1 mM EGTA, 2 mM (zx), 4 mM (O) or 8 mM ([]) 32p-labeled Pi and haloperidol as indicated. The 
reactions were stopped after 1 min with 5% trichloroacetic acid and 15 mM NaHEPO4; the mixtures were filtered (see Materials and 
Methods) and the radioactivity remaining in the filters was measured. The equilibrium of the reaction model shown in Scheme 2 was 
simulated (filled symbols): 
~x Pi
E , ~ , E.Pi • , E~P 
5 6 7 
3 4 
H.E ,, ~ ~ H.E.Pi . ~ H.E~P 
The equilibrium concentrations of the species were calculated with a computer program, by successive approximations up to an error 
lower than 0.1%. The following set of equilibrium constants were used: K 2 = [E. Pi]/[E ~ P] = 0.025, K 4 = [H. E. Pi]/[H • E ~ P] = 
0.125, and the dissociation constants K] = K 3 = 0.5 M, K 5 = K 6 = 1 - l0 -4 M, and K 7 = 5 • l0  -4  M. [Pi] = 2 mM (A ) ,  4 mM (0 )  or 8 
mM ([]), and the indicated concentrations of haloperidol (H) were assumed. (B) Double-reciprocal p ot of the phosphoenzyme against 
[Pi]. Data are taken from panel A. Haloperidol concentrations (mM) are 0 (O), 0.1 (0),  0.2 (v) ,  0.3 (v )  and 0.6 (rq). 
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the Ca-ATPase by high [Ca 2+ ] is presumably due to 
the replacement of Mg by Ca in the catalytic site. The 
phosphoenzyme thus formed has a very low turnover, 
and the steady-state ATPase activity decreases 
[2,8,25]. This must be taken into account o analyze 
the effect of haloperidol shown in Fig. 3: the in- 
hibitory effect is relatively large at optimal [Ca 2+ ] 
(10 IxM), and decreases upon [Ca 2+] increase. At 
suboptimal [Mg] (0.6 mM), the inhibitory effect of 
increasing [Ca 2+] becomes evident at lower [Ca2+], 
both in the presence as in the absence of haloperidol. 
For a high [Mg] (20 mM), Ca 2+ is unable to replace 
Mg in the catalytic site, and consequently unable to 
inhibit the ATPase activity, and the inhibitory effect 
of haloperidol disappeared. 
At a high free Ca concentration, the ATPase activ- 
ity is an increasing function of [Mg 2+ ] (Fig. 3, inset), 
and haloperidol does not have any inhibitory effect. 
This effect of Mg cannot be attributed to activation of 
the Ca 2+- or MgZ+-ATPase from T tubules, since this 
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Fig. 5. Effect of haloperidol n ATP-dependent Ca 2 + uptake. SR 
vesicles were preincubated in 0.9 ml of media with different 
concentrations of haloperidol and Mops-Tris (pH 7.0), at 37°C, 
20 min. Thereafter, the uptake reaction began by addition of 0.1 
ml of media with the other eactants. Final concentrations i  the 
incubation media were: 5 mM ATP, 3 mM MgC12, 100 mM KC1, 
50 mM Mops-Tris, 1 mg protein/ml SR membranes, haloperidol 
as indicated and either 100 IxM 45CAC12 plus 50 txM EGTA, in 
media containing 1.7% ethanol in all cases (©), or tracer amounts 
of 45CAC12, in media containing 1.1% ethanol in all cases (0). 
The reactions were stopped by filtration through 0.45 ~m Milli- 
pore filters, later washed with 3 ml of 2 mM LaCI 3, and counted 
in a liquid scintillation counter. Blanks without ATP were pre- 
pared and subtracted tothe experimental results. The results are 
expressed as percentages of Ca 2÷ uptake in the absence of 
haloperidol. 
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Fig. 6. Effect of haloperidol on the rate of Ca effiux from 
preloaded vesicles. SR vesicles (8 mg protein/ml) were equili- 
brated overnight in 10 mM 45CAC12, 100 mM KCI and 50 mM 
Mops-Tris (pH 7.0), at 4°C. Thereafter, the suspensions were 
diluted 50 times in 5 mM EGTA, 100 mM KCI, 50 mM 
Mops-Yris (pH 7.0), and 0 (O), 0.1 (X), 0.2 (zx) or 1.0 (©) mM 
haloperidol. Aliquots were taken at different imes after dilution 
and processed as indicated in Section 2 for determinations of the 
radioactivity retained by the membranes. The effiux media was at 
4°C and contained 1.5% (x,  z~) or 4.5% (©) ethanol. Controls 
without haloperidol (0)  in the absence or in the presence of 
1.5% or 4.5% ethanol are undistinguishable (data not shown). 
The zero time value was obtained immediately after dilution of 
the loaded SR vesicles in media with lanthanum and without 
haloperidol and EGTA. 
enzyme is activated either by Ca or Mg, and all the 
data were obtained with enough [Ca 2+ ] for full acti- 
vation [24]. 
The above results suggest hat haloperidol interacts 
with the catalytic site of the enzyme. This is also 
supported by the inhibitory effect of the drug on the 
phosphorylation by Pi, shown in Fig. 4, which occurs 
through step 3, Scheme 1; the phosphorylation reac- 
tions were carried out in the presence of 10 mM 
MgC12, at various Pi and haloperidol concentrations. 
The data (Fig. 4A, open symbols) were obtained at 
pH 7.0, but the results are qualitatively similar at pH 
6.0 (data not shown), a condition which increases the 
phosphorylation of the Ca-ATPase by Pi [3]. 
The phosphorylation results were analyzed by sim- 
ulation of the reaction model described in the legend 
to Fig. 4 (Scheme 2). The simulated results for each 
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pair of experimental Pi and haloperidol concentra- 
tions are included in Fig. 4A (filled symbols). Fig. 
4B shows the reciprocal of the experimental results 
from Fig. 4A plotted against he reciprocal of the Pi 
concentrations. The straight lines are drawn through 
values obtained from the simulation of the equilib- 
rium of the reaction model, for each concentration of
haloperidol. The concentration of the drug reducing 
phosphorylation by one half ranges within 0.10-0.12 
mM at the different Pi concentrations. 
ATP-dependent Ca uptake was measured after 
preincubations of the SR vesicles in different 
haloperidol concentrations (Fig. 5). The results ob- 
tained for two different Ca 2+ concentrations are simi- 
lar when expressed as percentages of Ca 2÷ uptake in 
the absence of the drug; the concentration of 
haloperidol reducing Ca uptake by one half is 0.15 
mM in both cases. The apparent Ki values for phos- 
phorylation (Fig. 4) and Ca uptake (Fig. 5) are simi- 
lar and lower than those measured for the inhibition 
of the ATPase activity (Fig. 1). 
The effect of haloperidol on the rate of Ca efflux 
from SR vesicles is shown in Fig. 6. SR vesicles 
were preloaded overnight in 10 mM (4SCa)CaC12 , 
and thereafter diluted 50 times in media with EGTA. 
The radioactivity retained by the membrane fraction 
was determined at different imes after dilution. The 
results show that halope, ridol increases the rate of Ca 
efflux from the vesicles. The effect is evident at 0.1 
mM haloperidol. 
4. Discussion 
We are reporting several effects of the neuroleptic 
agent haloperidol on the Ca-ATPase activity and Ca 
transport in SR membranes. The inhibitory effect of 
haloperidol on the ATPase activity is a complex 
function of the time of preexposure of the enzyme to 
the drug (Fig. 2), of the concentrations during prein- 
cubations and during catalysis (Fig. 1), and of the 
presence of divalent cations and their concentrations 
(Table 1 and Figs. 2 and 3). Fig. 1 clearly shows that 
the inhibition of the ATPase activity by haloperidol is 
enhanced by the previous exposure of the membranes 
to the drug. 
With regard to the effect of divalent cations on the 
inhibition of the Ca-ATPase by haloperidol, it should 
be taken into account that Mg z+ activates the Ca- 
ATPase as a cofactor of ATP in the catalytic site, and 
increases the rate of other steps of the cycle (Scheme 
1) [2,11]. These different effects of Mg 2+ are distin- 
guished in Fig. 3. The activating effect at low [Ca 2÷ ] 
(Fig. 3, empty circles vs empty squares) reflects the 
one at the catalytic site, which is inhibited at high 
[Ca:-] because of the replacement of Mg by Ca in 
this site [2,8,25]. This replacement can occur by 
several ways in a cycling enzyme, depending on the 
media composition, as discussed elsewhere [25,26]. 
The activating effect of Mg 2÷ on other steps is 
visualized in Fig. 3, insert, where Ca 2÷ saturates the 
catalytic ationic site. Haloperidol inhibits the activat- 
ing effect of Mg 2÷ on the catalytic site (Fig. 3, filled 
vs empty circles), but not the effect of Mg 2+ at other 
steps (Fig. 3, insert). A high Mg concentration (20 
mM) saturates the catalytic ationic site thus prevent- 
ing the inhibitory effect of both Ca and haloperidol 
(Fig. 3, triangles); Ca 2+ activates the enzyme with 
lower apparent affinity, indicated by the initial slope, 
and attributed to the decrease of the Ca 2÷ affinity in 
the transport sites by high Mg concentration [27,28]; 
this activating effect of Ca is not inhibited by 
haloperidol. The discussed results are consistent with 
the proposal that haloperidol affects the interaction of 
the metal moiety of the metal. ATP complex with its 
acceptor site. 
Table 1 and Fig. 2 show the effect of different 
preincubation conditions on the ATPase activity. Ac- 
cording to Scheme 1, in the absence of Ca e÷ and 
Mg 2÷ and before the addition of ATP, the enzyme 
should be under the E 2 form, while in the presence of 
Ca 2÷ and Mg 2÷, the predominant form should be 
Caz.E I. Then the results suggest that haloperidol 
interacts with the E e form of the enzymatic species, 
rather than with E~. 
This suggestion is further supported by the in- 
hibitory effect of haloperidol on the phosphorylation 
of the Ca-ATPase by Pi (Fig. 4), since Pi phosphory- 
lates the E 2 conformation (step 3, backward, in 
Scheme 1). For this reaction, it is known that prior to 
the formation of the covalent and acid-stable phos- 
phoenzyme, an acid-labile complex (Mg.E2.P i) is 
formed [7,19,29]. The reaction model described as 
Scheme 2 (Fig. 4) includes this intermediate of the 
phosphorylation reaction (Ee.Pi), where Mg is omit- 
ted for simplicity. The model postulates that haloperi- 
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dol binds either to the phosphorylated or to the 
dephosphorylated species, but with lower affinity for 
the covalent phosphoenzyme. The simulation of the 
equilibrium of the model fits well with the experi- 
mental results. Other alternatives, particularly the 
assumption of a lack of interaction of the drug with 
the covalent phosphoenzyme, do not adjust he exper- 
imental results satisfactorily. Scheme 2 predicts the 
formation of a finite phosphoenzyme amount at satu- 
rating haloperidol concentration, which depends on 
[P~]. It also predicts that the reciprocal plots of the 
phosphoenzyme levels against [Pi], in the presence of 
different concentrations of haloperidol, intercept a 
common point on the ordinate, as do the experimental 
results. 
The interaction of haloperidol with the catalytic 
site of the E 2 enzymatic conformation, discussed 
above, is in line with several previous observations: 
the catalytic site environment of the Ca-ATPase alter- 
nates between hydrophilic and hydrophobic states in 
the E 1 and E 2 conformations, respectively [30]. Some 
hydrophobic ompounds, such as propranolol and 
tetracaine, which inhibit the Ca-ATPase [15,16], in- 
teract with the catalytic site under the E 2 form. A 
hydrophobic photoactivable r agent used for studies 
of conformational changes in the active site [31] also 
interacts with the catalytic site of the E 2 conformer. 
Haloperidol impairs ATP-dependent Ca uptake at 
lower concentrations than those inhibiting the Ca- 
ATPase activity measured in the presence of a Ca 2 + 
ionophore (Figs. 5 and 1, respectively). In a prelimi- 
nary report from our laboratory [32] we observed that 
haloperidol activates the Ca-ATPase in the 0.1-0.3 
mM range, when measured in the absence of cal- 
cimycin. The result was explained assuming that 
haloperidol increases the Ca 2+ permeability of the 
membranes, thus preventing the effect of Ca 2+ accu- 
mulation within the vesicles which inhibits the Ca- 
ATPase activity. Now, we are showing (Fig. 6) a 
direct effect of haloperidol on Ca effiux from 
preloaded vesicles. Since the rate of Ca effiux is 
clearly enhanced at 0.1 mM haloperidol, the inhibi- 
tion of Ca uptake is better adscribed to an increased 
leakage rather than to inhibition of the active trans- 
port by inactivation of the Ca-ATPase, which occurs 
at higher concentrations. The results agree with previ- 
ous reports on the effect of other hydrophobic reagents 
on the Ca 2+ permeability of the SR membranes: 
several local anaesthetics increase the Ca 2+ perme- 
ability through SR membranes at concentrations 
which do not inhibit the Ca-ATPase activity [13,14]; 
on the basis of the protective ffect of the physio- 
logical ligands Ca and Mg, the increased Ca 2+ leak- 
age was later suggested to occur through the Ca- 
ATPase [33]. Trifluoperazine and other lipophilic 
agents inhibit the Ca-ATPase activity, Ca 2+ uptake, 
and the phosphorilation by P~ [15]; the inhibition of 
Ca 2+ uptake by trifluoperazine and other phenoti- 
azines was later demostrated to be a consequence of
an increased Ca 2+ effiux through the pump itself 
[16]. Thapsigargin, a highly specific inhibitor of the 
Ca-ATPase also antagonizes the effect of phenoti- 
azines and other lipophilic reagents on Ca effiux, 
which reinforces the proposal that the increased ef- 
flux occurs through the pump [34,35]. The increased 
Ca 2+ effiux promoted by phenotiazines i antago- 
nized by manipulations which withdraw the enzyme 
from the E 2 conformation, i.e. (Scheme 1), the satu- 
ration of the high affinity transport sites with Ca 2+ 
and the phosphorylation with Pi [34]. 
Summarizing, we showed several effects of 
haloperidol on Ca transport in SR membranes, which 
are common to those of other hydrophobic reactants: 
inhibition of the phosphorylation by P~, increase of 
the Ca permeability, inhibition of the Ca-ATPase 
activity, and protective ffect of Ca and Mg on some 
of these actions; they suggest a common molecular 
mechanism of action. Phenotiazines are among those 
previously studied agents, and therefore, in addition 
to the common neuroleptic actions of phenotiazines 
and haloperidol, these chemically different pharmaco- 
logical agents also share common effects on Ca 
handling in skeletal muscle fibers. We are aware that 
the concentrations affecting Ca transport here re- 
ported are undoubtedly larger than those needed in 
blood to exert a neuroleptic effect; for further specu- 
lations on the relation of the above findings and some 
peripheral effects of the drugs, experimental evi- 
dences are still lacking. 
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